Pemphigus vulgaris is a chronic blistering disease. Clinically it is characterized by painful intra-epidermal bullae and superficial vesicles involving both the skin and mucosal areas. The ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has reached over $13bn in global sales, which affirms its commercial advantage and sets a milestone for ...

Skin diseases are pathologic conditions that affect the body's surfaces (also called the integument), including skin, hair, nails and associated glands. They can involve all layers of the skin and ...

Department of Rheumatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Pemphigus vegetans (P Veg), the rarest subtype of pemphigus, is characterized by ...

He was instructed to continue the prednisone with an extended-taper dosing schedule in place. The onset and course of pemphigus vulgaris depend on the interaction between predisposing and inducing ...

paraneoplastic pemphigus, and pyoderma gangrenosum). The skin lesions may precede, be concurrent, or follow the detection of the associated cancer. Of greatest value are skin changes that appear ...